A double-blind, phase III study to evaluate the efficacy and safety of MRA [tocilizumab] in patients with RA [rheumatoid arthritis]

Next Previous
Trial Profile

A double-blind, phase III study to evaluate the efficacy and safety of MRA [tocilizumab] in patients with RA [rheumatoid arthritis]

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Dec 2005

At a glance

  • Drugs Methotrexate; Tocilizumab
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Chugai Pharmaceutical

    • Most Recent Events

    • 18 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top